glp 1 agonist drugs for weight loss GLP-1 Agonists Loss: Safe or Risky? How GLP-1 medications are transforming
Description
Conception and design: C
J Neurosci Res (2003) 72(5):60312
A systematic review and comparison of meta-analyses
55 In Alzheimer's disease, preliminary data suggest that liraglutide may reduce cognitive decline by up to 18% over one year compared to placebo by slowing brain atrophy in regions vital for memory, learning, language, and decision-making
Albiglutide, a long-acting GLP-1 receptor agonist, improves glycemia in type 2 diabetes: time-course analysis [abstract]
[DOI] [PMC free article] [PubMed] [Google Scholar] 5.Luo J., Feldman R., Kim K.C., et al
